Accumulation of clots causes some of the most severe symptoms of sickle cell disease, including strokes, kidney failure, ...

Acalabrutinib–Venetoclax improves progression-free survival and reduces disease progression in untreated chronic lymphocytic ...

This World Cancer Day, Leukaemia UK CEO Fiona Hazell explains why the government must act now to stop leukaemia devastating ...

Every four minutes, someone in the U.S. is diagnosed with blood cancer, and thousands of patients with blood cancers like ...

Unrelated cord blood transplant demonstrated efficacy in patients with blood cancer after microcystic adnexal carcinoma.

Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived ...

This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...

A 10-year-old boy with leukaemia is going to school and playing rugby matches despite being in hospital thanks to a robot.

Researchers observed an increase in both CXCR4 and CD5 levels as the cells progressed to later stages of the cell cycle, particularly in the S/G2/M phases.

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage.